Pierre Lestage Selected Research

S18986-1

6/2011	S 18986 reverses spatial working memory impairments in aged mice: comparison with memantine.
10/2010	DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Lestage Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 09/2009
6	Cognitive Dysfunction 05/2017 - 01/2002
4	Memory Disorders (Memory Loss) 05/2017 - 10/2010
2	Nervous System Diseases (Neurological Disorders) 03/2016 - 09/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2010 - 01/2002
1	Major Depressive Disorder (Major Depressive Disorders) 01/2017
1	Tremor (Tremors) 01/2017
1	Dementia (Dementias) 01/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2009
1	Schizophrenia (Dementia Praecox) 09/2009
1	Brain Diseases (Brain Disorder) 11/2007
1	Mental Disorders (Mental Disorder) 01/2005

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 05/2017 - 01/2005
3	Ionotropic Glutamate ReceptorsIBA 03/2016 - 11/2013
2	S 47445IBA 01/2019 - 01/2017
2	Donepezil (Aricept)FDA LinkGeneric 01/2019 - 06/2013
2	Memantine (Namenda)FDA Link 01/2019 - 06/2011
2	Neuroprotective AgentsIBA 01/2012 - 11/2007
2	S18986-1IBA 06/2011 - 10/2010
2	AMPA Receptors (AMPA Receptor)IBA 06/2011 - 10/2010
1	S 38093IBA 01/2019
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2019
1	Scopolamine (Hyoscine)FDA Link 05/2017
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 03/2016
1	AcidsIBA 03/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2012
1	Dihydrotachysterol (AT 10)IBA 06/2011
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2009
1	S 17092-1IBA 01/2002
1	NeuropeptidesIBA 01/2002

Therapy/Procedure

1	Therapeutics 06/2011